Skip to main content

Incyte news in 2026: 14 dated events

The latest Incyte event on this page is dated Nov 10, 2026. biobuzz.io reported: Wilmington’s Incyte Partners With Natera on Phase 2 Colorectal Cancer Trial Guided by MRD Testing.

Public (INCY)Pharmaceutical Manufacturing5,001 to 10,000 employeesincyte.comLinkedIn

Get Incyte's live signals in Claude or ChatGPT, or by API

AskWhat changed at Incyte this week? Use Autobound signals for incyte.com.
Dated events
14
Last 90 days
4
Latest
Nov 10, 2026

Source: Autobound Signal API · 75 signals tracked for Incyte · updated

News · latest 10

Latest Incyte news

  1. Partnership
    Wilmington’s Incyte Partners With Natera on Phase 2 Colorectal Cancer Trial Guided by MRD TestingIncyte entered into a clinical collaboration agreement with Natera to use its Signatera blood test to identify patients for a Phase 2 colorectal cancer trial evaluating investigational immunotherapy INCA33890.
  2. Earnings
    Incyte Reports $1.56 Billion Third-Quarter Revenue and Raises 2026 Sales GuidanceIncyte posted a GAAP net loss of $784.8 million for the third quarter of 2026.
  3. Launch
    Mirum Pharmaceuticals, Incyte announce FDA approval of AtebriozIncyte, in collaboration with Mirum Pharmaceuticals, received FDA approval for its Atebrioz tablets, a treatment for fibrodysplasia ossificans progressiva in patients aged 12 and older.
  4. Revenue
    Incyte stock reports 38 percent revenue growth as shares trade at USD 123.47Incyte reported Q2 2026 revenue of USD 1.67 billion, a 38% increase year-over-year.
  5. Earnings
    A Noteworthy Decision By Lee Heeson As Acquires $130K In Incyte Stock OptionsIncyte reported a gross margin of 91.79% and an EPS of 1.52.
  6. Acquisition
  7. Acquisition
  8. Acquisition
  9. News
  10. Integration

Showing 10 of 14 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Incyte with the Signal API

One POST /v1/companies/enrich call with incyte.com returns Incyte news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"incyte.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Incyte news

What is the latest news on Incyte?
The newest event on this page is dated Nov 10, 2026. biobuzz.io reported: Wilmington’s Incyte Partners With Natera on Phase 2 Colorectal Cancer Trial Guided by MRD Testing. This page lists 14 dated events for Incyte, each with a source link.
What is going on with Incyte?
The 10 latest events on this page cover partnership (1), earnings (2), launch (1), revenue (1), acquisition (3), news (1) and integration (1). The newest: Nov 10, 2026: Wilmington’s Incyte Partners With Natera on Phase 2 Colorectal Cancer Trial Guided by MRD Testing (biobuzz.io).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →